Peritransplant Soluble CD30 as a Risk Factor for Slow Kidney Allograft Function, Early Acute Rejection, Worse Long-Term Allograft Function, and Patients’ Survival

Table 3

Outcomes of early and late posttransplant period.

Outcomes	Recipients,
Delayed graft function, n (%)	9 (20.0)
Slow graft function, n (%)	7 (15.6)
Acute rejection episodes during follow-up,; n (%)	12 (26.7)
Very early (0–7th day), n (%)	5 (11.1)
Early (the 8th day–6 months), n (%)	4 (8.9)
Late (>6 months), n (%)	3 (6.7)
Pyelonephritis episodes during follow-up,; n (%)	7 (15.6)
Early (the 8th day–2 months), n (%)	5 (11.1)
Late (>6 months), n (%)	2 (4.4)
Death with functioning graft during follow-up,; n (%)	4 (8.9)
Graft failure during follow-up, n (%)	6 (13.3)

n: number of patients investigated. Numbers (percentages).